Skip to main content
. 2004 Jun 7;101(24):9121–9126. doi: 10.1073/pnas.0400520101

Fig. 5.

Fig. 5.

Effect of diabetes on corporal NOS activity and cGMP levels. (a) NOS activity as measured by calcium-dependent conversion of l-arginine to l-citrulline. (b) cGMP levels in control and STZ-diabetic rats corporal tissue after intracavernosal administration of vehicle, AAVCMVβgal, and AAVT19NRhoA. n, number of tissue samples; *, P < 0.05 when compared to control; **, P < 0.05 when compared to STZ-diabetic tissue treated with vehicle or AAVCMVβgal.